BATM Advanced Communications Ltd. (LON:BVC)
15.00
+0.50 (3.45%)
Jul 7, 2026, 4:35 PM GMT
LON:BVC Market Cap
LON:BVC has a market cap or net worth of 51.01 million as of July 7, 2026. Its market cap has decreased by -27.87% in one year.
Market Cap
51.01M
Enterprise Value
40.25M
Revenue
91.54M
Ranking
n/a
PE Ratio
n/a
Stock Price
15.00
Market Cap Chart
Since March 30, 1998, LON:BVC's market cap has increased from 47.21M to 51.01M, an increase of 8.06%. That is a compound annual growth rate of 0.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 51.01M | -27.59% |
| Dec 31, 2025 | 70.45M | -12.53% |
| Dec 31, 2024 | 80.54M | -8.79% |
| Dec 29, 2023 | 88.30M | -26.09% |
| Dec 30, 2022 | 119.47M | -67.74% |
| Dec 31, 2021 | 370.41M | -9.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 224.21B |
| GSK plc | 80.29B |
| Haleon | 32.12B |
| Smith & Nephew | 9.56B |
| Shield Therapeutics | 65.71M |
| ECO Animal Health Group | 64.71M |
| Kooth | 58.40M |
| Hemogenyx Pharmaceuticals | 52.36M |